(Q42536282)

1 November 2017

Design, synthesis, and conformational analysis of a novel series of HIV protease inhibitors (English)

1 reference

1 November 2017

Baker CT

1

1 reference

1 November 2017

Salituro FG

2

1 reference

1 November 2017

Court JJ

3

1 reference

1 November 2017

Deininger DD

4

1 reference

1 November 2017

Kim EE

5

1 reference

1 November 2017

Li B

6

1 reference

1 November 2017

Novak PM

7

1 reference

1 November 2017

Rao BG

8

1 reference

1 November 2017

Pazhanisamy S

9

1 reference

1 November 2017

Schairer WC

10

1 reference

1 November 2017

Tung RD

11

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 December 1998

1 reference

Bioorganic & Medicinal Chemistry Letters

1 November 2017

1 reference

1 November 2017

8

1 reference

1 November 2017

24

1 reference

1 November 2017

3631-3636

1 reference

1 November 2017

HIV-protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900669-6

7 January 2021

In vitro selection and characterization of human immunodeficiency virus type 1 (HIV-1) isolates with reduced sensitivity to hydroxyethylamino sulfonamide inhibitors of HIV-1 aspartyl protease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900669-6

7 January 2021

Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900669-6

7 January 2021

On the size of the active site in proteases. I. Papain

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900669-6

7 January 2021

Expedient method for the solid-phase synthesis of aspartic acid protease inhibitors directed toward the generation of libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900669-6

7 January 2021

Kinetic characterization of human immunodeficiency virus type-1 protease-resistant variants

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900669-6

7 January 2021

Nonpeptidal P2 ligands for HIV protease inhibitors: structure-based design, synthesis, and biological evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900669-6

7 January 2021

Potent HIV protease inhibitors incorporating high-affinity P2-ligands and (R)-(hydroxyethylamino)sulfonamide isostere

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900669-6

7 January 2021

Benzocycloalkyl amines as novel C-termini for HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900669-6

7 January 2021

Design and synthesis of novel conformationally restricted HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900669-6

7 January 2021

10.1016/S0960-894X(98)00669-6

Identifiers

DOI

1 reference

1 November 2017

1 reference